Europe — EMA
Paliperidon Teva (Paliperidone Palmitate)
GNH USA supplies Paliperidon Teva (Paliperidone palmitate), an antipsychotic for schizophrenia and schizoaffective disorder. Request a quote for supply.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidon Teva, is an atypical antipsychotic presented as an intramuscular injection for intramuscular use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adult patients, providing long‑acting symptom control.
GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring reliable quality and regulatory compliance across markets. Our distribution network adheres to stringent cold‑chain standards where required, and we provide comprehensive documentation to facilitate import and registration processes.
What is Paliperidone Palmitate used for?
Paliperidone palmitate is an atypical antipsychotic used in the management of chronic psychotic disorders. - Schizophrenia: reduces relapse risk and maintains symptom control in adult patients. - Schizoaffective disorder: helps stabilize mood and psychotic symptoms as part of maintenance therapy. - Maintenance treatment of schizophrenia: provides long‑acting injectable therapy to improve adherence.
What are the side effects of Paliperidone Palmitate?
Paliperidone palmitate may be associated with a range of adverse reactions, which are categorized by frequency and severity.
Common Side Effects: - Injection site pain: discomfort at the injection site. - Weight gain: increase in body weight. - Akathisia: restlessness or urge to move. - Sedation: drowsiness or reduced alertness.
Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Tardive dyskinesia: persistent involuntary movements. - Orthostatic hypotension: significant drop in blood pressure on standing. - Severe allergic reactions: anaphylaxis or angioedema.
What precautions apply to Paliperidone Palmitate?
When prescribing paliperidone palmitate, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiovascular status: monitor for orthostatic hypotension and arrhythmias. - Evaluate metabolic profile: watch for weight gain, glucose, and lipid changes. - Screen for movement disorders: monitor for extrapyramidal symptoms and tardive dyskinesia. - Review concomitant medications: avoid drugs that prolong QT interval. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep in original packaging, protect from moisture and light.
What does Paliperidone Palmitate interact with?
Paliperidone palmitate can interact with other medicines, affecting its efficacy or safety.
Major Interactions (Avoid): - Strong CYP3A4 inducers: may reduce plasma levels and effectiveness. - QT‑prolonging agents: increase risk of cardiac arrhythmias. - Antihypertensive drugs: additive effect on blood pressure lowering.
Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors: may raise paliperidone concentrations. - CNS depressants: enhance sedation or dizziness. - Anticholinergic agents: may worsen cognitive side effects.



